|
Diabetes, Vol 43, Issue 2 180-190, Copyright © 1994 by American Diabetes Association
Dynamics of glucose production and uptake are more closely related to insulin in hindlimb lymph than in thoracic duct lymph
RA Poulin, GM Steil, DM Moore, M Ader and RN Bergman
Department of Physiology and Biophysics, University of Southern California, Los Angeles 90033.
We previously reported a striking similarity between the dynamics of both
glucose turnover and thoracic duct lymph insulin during euglycemic clamps
(J Clin Invest 84:1620, 1989), which suggested that transendothelial
insulin transport (TET) is rate-limiting for insulin action in vivo.
Thoracic duct lymph, however, is primarily derived from insulin-insensitive
tissues, which raises questions as to the physiological significance of
this relationship. The relationship between glucose turnover and TET was
thus examined in insulin-sensitive tissues by the simultaneous measurement
of insulin in plasma, thoracic duct lymph, and hindlimb lymph during
euglycemic clamps in normal anesthetized dogs (n = 8). Clamps consisted of
two 3-h phases: a 0.6 mU.min-1.kg-1 insulin infusion (activation phase)
followed by termination of the insulin infusion (deactivation phase). Lymph
insulin was less than plasma insulin during both phases (P < 0.01) with
steady-state hindlimb (120 +/- 12 pM) and thoracic duct lymph insulin (138
+/- 12 pM) 38 and 45%, respectively, lower than steady-state plasma insulin
(222 +/- 24 pM) at the end of the activation phase (P < 0.05). Also, the
rate of increase of lymph insulin was slower than plasma insulin during
hormone infusion; half-time to steady-state was 8.8 +/- 2.0 min for plasma
insulin, but longer for thoracic (25.8 +/- 3.5) and hindlimb lymph insulin
(40.7 +/- 5.7 min). A very close relationship was observed during
activation between the rate of increase of glucose uptake (Rd) and the
increase in hindlimb lymph insulin (r2 = 0.92); this relationship was
weaker for thoracic lymph (r2 = 0.74) and much weaker between glucose
uptake and plasma insulin (r2 = 0.35). These data support the concept that
interstitial insulin (represented by hindlimb lymph) is the signal that
determines glucose uptake by insulin-sensitive tissues and that the rate of
increase of glucose uptake is determined by transendothelial insulin
transport into insulin-sensitive tissue. Also, during activation, hindlimb
lymph insulin was a very strong predictor of the rate of suppression of
hepatic glucose output (HGO) (r2 = 0.96), and the correlation with HGO was
stronger than that for thoracic lymph (r2 = 0.85). The evidence that the
rate of increase of Rd and the rate of suppression of HGO during insulin
infusion are very strongly predicted by the time course of insulin in
hindlimb lymph is consistent with the single-gateway hypothesis: the
insulin transport rate across endothelium in insulin-sensitive tissue
(skeletal muscle) determines the rate of glucose utilization and the
suppression of hepatic glucose output.(ABSTRACT TRUNCATED AT 400 WORDS)

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. D. Chiu, J. M. Richey, L. N. Harrison, E. Zuniga, C. M. Kolka, E. Kirkman, M. Ellmerer, and R. N. Bergman
Direct Administration of Insulin Into Skeletal Muscle Reveals That the Transport of Insulin Across the Capillary Endothelium Limits the Time Course of Insulin to Activate Glucose Disposal
Diabetes,
April 1, 2008;
57(4):
828 - 835.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Eggleston, L. A. Jahn, and E. J. Barrett
Hyperinsulinemia Rapidly Increases Human Muscle Microvascular Perfusion but Fails to Increase Muscle Insulin Clearance: Evidence That a Saturable Process Mediates Muscle Insulin Uptake
Diabetes,
December 1, 2007;
56(12):
2958 - 2963.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ellmerer, M. Hamilton-Wessler, S. P. Kim, K. Huecking, E. Kirkman, J. Chiu, J. Richey, and R. N. Bergman
Reduced Access to Insulin-Sensitive Tissues in Dogs With Obesity Secondary to Increased Fat Intake
Diabetes,
June 1, 2006;
55(6):
1769 - 1775.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bodenlenz, L. A. Schaupp, T. Druml, R. Sommer, A. Wutte, H. C. Schaller, F. Sinner, P. Wach, and T. R. Pieber
Measurement of interstitial insulin in human adipose and muscle tissue under moderate hyperinsulinemia by means of direct interstitial access
Am J Physiol Endocrinol Metab,
August 1, 2005;
289(2):
E296 - E300.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Christopher, C. Rantzau, G. McConell, B. E. Kemp, and F. P. Alford
Prevailing hyperglycemia is critical in the regulation of glucose metabolism during exercise in poorly controlled alloxan-diabetic dogs
J Appl Physiol,
March 1, 2005;
98(3):
930 - 939.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ellmerer, S. P. Kim, M. Hamilton-Wessler, K. Hucking, E. Kirkman, and R. N. Bergman
Physiological Hyperinsulinemia in Dogs Augments Access of Macromolecules to Insulin-Sensitive Tissues
Diabetes,
November 1, 2004;
53(11):
2741 - 2747.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Caumo and L. Luzi
First-phase insulin secretion: does it exist in real life? Considerations on shape and function
Am J Physiol Endocrinol Metab,
September 1, 2004;
287(3):
E371 - E385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ellmerer, M. Hamilton-Wessler, S. P. Kim, M. K. Dea, E. Kirkman, A. Perianayagam, J. Markussen, and R. N. Bergman
Mechanism of Action in Dogs of Slow-Acting Insulin Analog O346
J. Clin. Endocrinol. Metab.,
May 1, 2003;
88(5):
2256 - 2262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hamilton-Wessler, M. Ader, M. K. Dea, D. Moore, M. Loftager, J. Markussen, and R. N. Bergman
Mode of Transcapillary Transport of Insulin and Insulin Analog NN304 in Dog Hindlimb: Evidence for Passive Diffusion
Diabetes,
March 1, 2002;
51(3):
574 - 582.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Dea, M. Hamilton-Wessler, M. Ader, D. Moore, L. Schaffer, M. Loftager, A. Volund, and R. N. Bergman
Albumin Binding of Acylated Insulin (NN304) Does Not Deter Action to Stimulate Glucose Uptake
Diabetes,
March 1, 2002;
51(3):
762 - 769.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Kirwan, L. F. del Aguila, J. M. Hernandez, D. L. Williamson, D. J. O'Gorman, R. Lewis, and R. K. Krishnan
Regular exercise enhances insulin activation of IRS-1-associated PI3-kinase in human skeletal muscle
J Appl Physiol,
February 1, 2000;
88(2):
797 - 803.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Richey, M. Ader, D. Moore, and R. N. Bergman
Angiotensin II induces insulin resistance independent of changes in interstitial insulin
Am J Physiol Endocrinol Metab,
November 1, 1999;
277(5):
E920 - E926.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Rebrin, G. M. Steil, W. P. van Antwerp, and J. J. Mastrototaro
Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring
Am J Physiol Endocrinol Metab,
September 1, 1999;
277(3):
E561 - E571.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1994 by the American Diabetes Association.
|
|
| |
|